Perrigo Ordinary Shares reported $4.84B in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Bayer BAYN:GR EUR 38.77B 2.5B
Catalent CTLT:US USD 4.91B 212M
Coherus Biosciences CHRS:US USD -137418000 40.28M
Corcept Therapeutics CORT:US USD 501.84M 28.48M
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
Horizon Pharma HZNP:US USD 5.07B 38.49M
Lannett LCI:US USD -312274000 34.71M
Nestle NESN:VX 41.98B 2.47B
Pacira Pharmaceuticals PCRX:US USD 775.01M 4.89M
Perrigo Ordinary Shares PRGO:US USD 4.84B 239.4M
Phibro Animal Health PAHC:US USD 268.37M 5.61M
Prestige Brands PBH:US USD 1.69B 67.02M
Reckitt Benckiser Group PLC RB/:LN GBP 9.44B 518M
Supernus Pharmaceuticals SUPN:US USD 886.2M 33.41M
Teva Pharmaceutical TEVA:IT USD 7.9B 871M
Xeris Pharmaceuticals Inc XERS:US USD 45.19M 9.85M
Zoetis ZTS:US USD 4.4B 258M